Asset Management One Co., Ltd. I Mab Transaction History

Asset Management One Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$8.27 - $18.43 $91,251 - $203,356	-11,034 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$45.28 - $74.5 $56,826 - $93,497	1,255 Added 12.83%	11,034 $503,000
Q3 2021 Nov 02, 2021	BUY	$57.18 - $84.43 $49,689 - $73,369	869 Added 9.75%	9,779 $708,000
Q2 2021 Aug 03, 2021	BUY	$47.86 - $83.95 $426,432 - $747,994	8,910 New	8,910 $747,000

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $74.8M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.